Myths vs facts: CYP2D6 and allergy

Myth: CYP2D6 variants directly determine your allergy risk. Fact: CYP2D6 is a drug-metabolizing enzyme primarily affecting how you process medications like codeine, antidepressants, and beta-blockers. Evidence for a direct link to allergies or hay fever is weak and inconsistent. Some observational studies suggest weak associations with asthma or atopic dermatitis, but effect sizes are small and not reproducible. The allergic immune response is mainly driven by immune system genes (e.g., HLA, IL-4, FCER1A). A CYP2D6 genetic test therefore provides no clinically actionable information about your allergy risk. Evidence is human-observational/unclear. Caveat: No large GWAS or RCTs support a causal relationship. Rely on established allergy diagnostics (skin prick test, IgE) rather than consumer DNA tests for lifestyle products.